Hydroxychlorquine reportedly "directly reduces the binding of antiphospholipid [[antibody]]–β2-glycoprotein I complexes to phospholipid bilayers":<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518879/</ref> | Hydroxychlorquine reportedly "directly reduces the binding of antiphospholipid [[antibody]]–β2-glycoprotein I complexes to phospholipid bilayers":<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518879/</ref> |